With highly effective B cell depletion therapy, this population re-emerged in the CSF of MS patients, with associated increases in myeloid TNFα expression in both CSF and blood, suggesting an important role in autoimmune disease pathogenesis 17. The gene discussed is TNF; the disease is myeloid sarcoma.